drug
plazomicin sulfate
Marketedupdated 3mo agoby Cipla USA Inc
Approvedcommunity read0 votes
all catalysts(0)
nothing on the calendar yet
Patent cliff
source: FDA Orange Bookfirst barrier falls
Jun 25, 2028
~1.8 years out
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (4)
- Jun 25, 2032compositionUS 8383596
- Nov 21, 2028formulationUS 88224242.3y
- Nov 21, 2028method-of-use (U-2328)US 92669192.3y
- Nov 21, 2028compositionUS 96887112.3y
FDA exclusivities (2)
- Jun 25, 2028GAINGAIN Antibiotic (5y)1.8y
- Jun 25, 2023NCENew Chemical Entity (5y)
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 6m ago
Found something off?
comments(0)
5-min edit window · permanent after that